Engineered immune cells elicit broad response to HIV in mice, offering hope for vaccine 11/20/2020 Health News, Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus—which continues to...
Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis 12/04/2018 Medications, CAMBRIDGE, Mass., Dec. 2, 2018 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in...